Indoco Remedies launches Favipiravir 400 mg tablets in India

28 Sep 2020 Evaluate

Indoco Remedies has launched FEVINDO (Favipiravir) 400 mg Tablets in India. Fevindo ? 400 (Favipiravir) is an antiviral drug, effective against the RNA?based influenza virus. The drug has been approved by DCGI in the treatment of Covid?19. Fevindo 400 reduces pill burden by 50% and ensures convenient dosing and better patient compliance.

Fevindo ? 400 (Favipiravir) will be made available at all government approved COVID care centres and selected medical practitioners across the country. In addition to Fevindo, Indoco has two more new products for launch in Covid Care range, i.e., Povidone Iodine Gargle and Immunity booster chewable tablets with Zinc, Vitamin C and Vitamin D. The company has always been committed to provide quality medicines at affordable prices and with the launch of these products, the Company is all set to venture into the treatment of Covid? 19.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

251.75 0.50 (0.20%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×